Identifying blood markers that predict heart failure complications
Official title: Blood Biomarkers Associated with Adverse Outcomes in Heart Failure
Funded at State University New York Stony Brook · NIH-11043732 · Data updated 2026-11-12
This study is looking at certain blood tests that might help doctors find out which heart failure patients are more likely to have problems with their heart and kidneys, so they can make better treatment decisions for everyone, whether their heart function is strong or weak.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University New York Stony Brook NIH-funded |
| Lab location | 1 site (Stony Brook, United States) |
| Project start | February 27, 2024 |
| Project end | March 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $119,625 |
| NIH project number | 7R21HL168476-02 |
| Project ID | NIH-11043732 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with heart failure, particularly those with preserved or reduced ejection fraction.
✕Less likely to help
Patients without heart failure or those with other unrelated cardiovascular conditions may not benefit from this research.
What this research studies
This research investigates blood biomarkers that can help identify patients with heart failure who are at increased risk for adverse cardiovascular and kidney outcomes. It focuses on patients with both preserved and reduced ejection fraction heart failure, aiming to determine which biomarkers are most effective in predicting declines in kidney function and related complications. By analyzing various biomarkers, including serum creatinine and cystatin C, the study seeks to improve prognostication and clinical decision-making for patients with heart failure.
Why it matters
Potential benefit: If successful, this research could lead to better identification of patients at risk for serious complications, allowing for timely interventions and improved management of heart failure.
How similar studies have gone: Previous research has shown promise in using blood biomarkers to predict outcomes in heart failure, suggesting that this approach may yield valuable insights.
Where this research is happening
-
State University New York Stony Brook
Stony Brook, United States Active
Researchers
- Principal investigator: Hedayati, Susan — State University New York Stony Brook
- Study coordinator: Hedayati, Susan
Related research
Other NIH-funded projects on the same topics.
-
AI-supported heart failure diagnosis and management in Rwanda
Aiming to help people with suspected heart failure in Rwanda get faster, more accurate diagnoses and better care using AI-guided ultrasound and care protocols.
-
AI-assisted heart failure diagnosis in Rwanda using focused ultrasound
An NIH-funded project will test whether AI-enhanced, easy-to-use heart ultrasound can help non-experts diagnose and manage heart failure in Rwanda.
-
HF endotypes in heart failure using ethical multi-modal AI and molecular data
A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.
-
Triple gene therapy approach to heal the heart after a heart attack
A new therapy combines three genetic approaches delivered by a virus to help the heart heal after a heart attack.
-
Digital-first heart failure care delivery in Uganda
A targeted program in Uganda tests a digital care plan to help people with heart failure manage their symptoms at home.
-
Digital-first heart failure care delivery in Uganda
A study to test digital self-care tools to help people with heart failure in Uganda manage symptoms and stay healthier.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.